Bold Vision.
Innovation at its best.

For almost 30 years, ProPhase has been relentlessly focused on enhancing wellness and improving health. Historically, we have been a diversified medical science and technology company that delivers breakthrough, clinically shown supplements and OTC manufacturing. In 2020, we pivoted to build out state of the art CLIA labs for COVID-19 diagnostic testing. In 2021, we acquired Nebula Genomics and formed ProPhase Precision Medicine. We are rapidly developing into a true diagnostics and genomics company that will leverage our CLIA laboratories for COVID-19 Testing, whole genome sequencing and a wide variety of diagnostic testing.

Lab Processing

Diagnostic Labs

  • Highly accurate COVID-19 PCR testing in our two state-of-the-art CLIA laboratories.
  • Also offering our best-in-class rapid antigen and antibody testing.
  • Next goal: A fully integrated Diagnostic Laboratory service with a complete clinical lab offering.
Learn More


  • The Nebula Whole Genome Sequencing test decodes 100% of the genome and provides up to 5,000x more data than other well-known consumer genetic tests.
  • This extremely accurate DNA test provides information on genetic mutations and examines your ancestry, health, diet and physical activity.
  • Nebula provides an online report with weekly updates to help our customers stay informed about the newest genetic insights and how this relates to a customer’s personal genetic makeup.
Learn More
Contract Manufacturing

Contract Manufacturing

  • 30+ years of OTC manufacturing services and consumer healthcare product development for contract and private label customers.
  • Capabilities range from non-GMO, Organic and/or Natural-based cough drops and lozenges for over-the-counter drug to dietary supplement products.
Learn More

Dietary Supplements

  • Line of consumer products that promote better health, energy, and sexual vitality.
  • Featuring formulas with clinical studies to back important claims.
  • Available online and in major Food Drug and Mass retail stores including Walmart, Walgreens, CVS, Rite-Aid and more.
Learn More

Next Goals

ProPhase Global Healthcare

International COVID-19 healthcare-related initiatives including testing facilities leveraging scientific and testing capabilities

ProPhase Precision Medicine

Developing cutting-edge technologies in genomics testing to predict disease risk, characterize genetic mutations, and identify inherited disorders and drug response, including those that drive cancer progression.

Press Releases

See our latest innovations and breaking news

Jun 28 2022 8:30AM ET

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

Read More

Jun 13 2022 8:30AM ET

ProPhase Labs Announces Significant Laboratory Expansion

Read More

May 18 2022 8:15AM ET

ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference

Read More
Investor Relations

Get In Touch

We care about your questions and will be in touch usually within 24 hours

This field is for validation purposes and should be left unchanged.
Dev Tool:

Request: None
Matched Rewrite Rule: None
Matched Rewrite Query: None
Loaded Template: front-page.php